Abstract
Pfizer is one of the world’s leading research-based pharmaceutical companies; discovering, developing, manufacturing and marketing innovative medicines. The company was founded in 1849, and by 2012 it had grown into a $59 billion global enterprise with more than 88,000 employees and an annual R&D spending of $7.9 billion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Bernstein Research (2011) The long view: is there light at the end of the pharmaceutical “patent cliff” tunnel? New models to 2020
Jackson TL (2006) Hoshin Kanri for the lean enterprise: developing competitive capabilities and managing profit. CRC Press, Boca Raton. ISBN 978-1-56327-342-1
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Seller, C., Davis, R. (2013). From Process Stabilization to Plant Network Performance: Pfizer’s Journey to Operational Excellence. In: Friedli, T., Basu, P., Bellm, D., Werani, J. (eds) Leading Pharmaceutical Operational Excellence. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35161-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-35161-7_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35160-0
Online ISBN: 978-3-642-35161-7
eBook Packages: Business and EconomicsBusiness and Management (R0)